Last reviewed · How we verify
Best standard of care (BSoC) — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Best standard of care (BSoC) (Best standard of care (BSoC)) — Bayer. Best standard of care (BSoC) is a comparator arm designation used in clinical trials, not a drug with a specific mechanism of action.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Best standard of care (BSoC) TARGET | Best standard of care (BSoC) | Bayer | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Best standard of care (BSoC) CI watch — RSS
- Best standard of care (BSoC) CI watch — Atom
- Best standard of care (BSoC) CI watch — JSON
- Best standard of care (BSoC) alone — RSS
Cite this brief
Drug Landscape (2026). Best standard of care (BSoC) — Competitive Intelligence Brief. https://druglandscape.com/ci/best-standard-of-care-bsoc. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab